Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
H. Pylori/Ulcer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - H. Pylori/Ulcer
    TopAbstracts in H. Pylori/Ulcer 08/26/2008 - (DGNews)
    Long-Term Use of Proton Pump Inhibitors Increases Fracture Risk - (DGNews)
    H Pylori Eradication Lowers Risk of Redeveloping Stomach Cancer - (DGNews)
    TopAbstracts in H. Pylori/Ulcer 07/29/2008 - (DGNews)
    ASGE Issues Guidelines for Endoscopy in Bariatric Surgery Patients - (DGNews)

    News archive

     Recent webcasts/CME

      Webcasts/CME archive

       Recent cases - H. Pylori/Ulcer
        Primary Gastric Lymphoma and Helicobacter Pylori Infection with Gastric Amyloidosis
        Gastric Adenocarcinoma in a Patient Re-Infected with H. Pylori after Regression of MALT Lymphoma with Successful Anti-H. Pyloritherapy and Gastric Resection
        Helicobacter Pylori
        Perforated Gastric Ulcer in a Young Girl
        Peptic Ulcer Disease

        Cases archive
          




        my personal edition > h. pylori/ulcer > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Rabeprazole Plus Antibiotics Effectively Eradicates Helicobacter Pylori Infection

        A DGReview of :"Rabeprazole-based therapies in Helicobacter pylori eradication"
        Alimentary Pharmacology & Therapeutics

        03/26/2003
        By David Ball


        Rabeprazole, in combination with two antibiotics, can effectively eradicate Helicobacter Pylori infection, say Spanish researchers.

        Eradication rates with the combination are similar to those achieved by omeprazole and lansoprazole when co-prescribed with antibiotics.

        This systematic review of reported studies on the efficacy of rabeprazole-based therapies and a meta-analysis comparing it to other proton pump inhibitors plus antibiotics was conducted by J.P. Gisbert and researchers at the Hospital Universitario de la Princesa, Madrid, and Hospital de Sabadell, Institut Universitary Parc Tauli, Barcelona, Spain. Their meta-analysis of randomised trials included those comparing rabeprazole and other proton pump inhibitors with antibiotics.

        Electronic and manual bibliographic searches and calculations were made of the percentage (weighted mean) of successful eradication. Odds ratios (OR) of the individual studies were combined for the meta-analysis.

        Eradication rates for the 14-day rabeprazole-amoxicillin combination were 73% and for rabeprazole-amoxicillin-clarithromycin 44% at 3 days, 72% at 5 days, 78% at 7 days and 75% at 10 days.

        For low-dose rabeprazole, 20 mg/day plus amoxicillin and clarithromycin, the eradication rate over 7 days was 81% and for high-dose rabeprazole, 40 mg/day, with amoxicillin and clarithromycin, 75%. For 7 days with the rabeprazole-clarithromycin-nitroimidazole combination, it was 85%.

        The meta-analysis included 12 comparative studies.

        With rabeprazole plus antibiotics the eradication rate was 79% and with other proton pump inhibitors it was 77% (OR = 1.15; 95% confidence interval, 0.93-1.42).

        No difference was seen in sub-analysis comparison of rabeprazole at low doses,10 mg twice daily, with other proton pump inhibitors at standard doses, omeprazole 20 mg twice daily or lansoprazole 30 mg twice daily.
        Aliment Pharmacol Ther 2003 Mar;17:6:751-64. "Rabeprazole-based therapies in Helicobacter pylori eradication"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send